Merck (NYSE:MRK) reported new Phase 3 data for belzutifan based WELIREG regimens in renal cell carcinoma, showing meaningful ...

Merck said on Monday it would split its business into two, creating ⁠a division for its cancer franchise while grouping its ​non-oncology treatments separately.

The drugmaker is splitting its pharmaceuticals unit to bolster product launches before a crucial patent loss.

Merck reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. But Merck posted a modest 2026 outlook that ...

Although Merck (NYSE:MRK) is confronted with the unavoidable Keytruda patent cliff in 2028, the company is strategically positioning itself for further growth by diversifying and expanding its ...

Keytruda, Merck's flagship oncology drug, drives significant revenue growth, with a solid market position and patent protection ensuring continued growth. Merck is the second largest player in the ...

Merck reported third-quarter revenue and adjusted earnings that topped expectations. The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal ...

Merck aims to cut $3B in costs by end of 2027 Job reductions planned across admin, sales and R&D Company to shrink global real estate and manufacturing Savings to support biotech, R&D and Keytruda ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

Merck is preparing to cut about 150 jobs at its new vaccine plant in Durham, North Carolina, a move that ties a very local ...

Merck headquarters in Rahway, NJ. RAWAY, N.J. – Merck today announced fourth quarter earnings and revenue that beat Wall Street estimates. However, Merck, the giant pharmaceutical company with ...

Merck is seeking ways to prepare for a significant upcoming patent cliff. The company has just announced another acquisition that will help it achieve that goal. With its newer products, strong ...